Kogieleum Naidoo

Kogieleum Naidoo is a South African scientist, researcher and academic at University of KwaZulu-Natal. Her research work has a focus on the HIV & AIDS infection with focus advancing care for individuals affected by Tuberculosis and AIDS. Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Kogieleum Naidoo', query time: 0.02s Refine Results
  1. 1
    Aetiology, Clinical Presentation, and Outcome of Meningitis in Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis

    Aetiology, Clinical Presentation, and Outcome of Meningitis in Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis by Smita Bhagwan, Kogieleum Naidoo

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Long COVID: An approach to clinical assessment and management in primary care

    Long COVID: An approach to clinical assessment and management in primary care by Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo

    Published 2023-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    HIV-Associated Tuberculosis

    HIV-Associated Tuberculosis by Kogieleum Naidoo, Kasavan Naidoo, Nesri Padayatchi, Quarraisha Abdool Karim

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Low rifampicin concentrations in tuberculosis patients with HIV infection

    Low rifampicin concentrations in tuberculosis patients with HIV infection by Tanuja Narayansamy Gengiah, Julia Hillary Botha, Deepak Soowamber, Kogieleum Naidoo, Salim S Abdool Karim

    Published 2014-08-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis.

    Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis. by Halima Dawood, Nonhlanhla Yende-Zuma, Upasna Singh, Mikaila C Moodley, Jenine Ramruthan, Kogieleum Naidoo

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    High mortality among patients with tuberculosis accessing primary care facilities: secondary analysis from an open-label cluster-randomised trialResearch in context

    High mortality among patients with tuberculosis accessing primary care facilities: secondary analysis from an open-label cluster-randomised trialResearch in context by Kogieleum Naidoo, Nonhlanhla Yende Zuma, Mikaila Moodley, Felix Made, Rubeshan Perumal, Santhanalakshmi Gengiah, Jacqueline Ngozo, Nesri Padayatchi, Andrew Nunn, Salim Abdool Karim

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis

    Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an int... by Richard John Lessells, Kogieleum Naidoo, Nigel Garrett, Jienchi Dorward, Lara Lewis, Christian Bottomley, Yukteshwar Sookrajh, Kwabena Asare, Johan van der Molen, Thokozani Khubone, Thulani Ngwenya, Ntokozo Siyabonga Mkhize, Phelelani Sosibo

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.

    Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries. by Sara Keller, Kogieleum Naidoo, Medhane Zekarias, Sussan Israel-Isah, Mohammed Shaka, Gcinile Gule, Anushka Naidoo, Miriam Bathnna, Judith Nomthandazo Dlamini-Miti, Kalkidan Yae, Evaezi Okpokoro, Alash'le Abimiku, Ahmed Bedru, Edine W Tiemersma, TRiAD Study Consortium

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries

    Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries by Sara Keller, Kogieleum Naidoo, Medhane Zekarias, Sussan Israel-Isah, Mohammed Shaka, Gcinile Gule, Anushka Naidoo, Miriam Bathnna, Judith Nomthandazo Dlamini-Miti, Kalkidan Yae, Evaezi Okpokoro, Alash’le Abimiku, Ahmed Bedru, Edine W. Tiemersma, on behalf of the TRiAD Study Consortium

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

    Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/X... by Kogieleum Naidoo, Derek J Sloan, Wilber Sabiiti, Bariki Mtafya, Stephen H Gillespie, Aderonke Agbaje, Nyanda Elias Ntinginya, Morten Ruhwald, Agnes Gebhard, Anushka Naidoo, Rubeshan Perumal, Getachew Tollera, Evaezi Okpokoro, Alash'le G Abimiku, Everdina W Tiemersma, Sabine M Hermans, Sophia B Georghiou, Kalkidan Yae, Shewki Moga, Hannelise Feyt, Takondwa Kachoka, Marothi P Letsoalo, Andrea M Cabibbe, Letitia Shunmugam, Daniela M Cirillo, Salah Foraida

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: